Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models.
Elliott M, Favre-Guilmard C, Liu SM, Maignel J, Masuyer G, Beard M, Boone C, Carré D, Kalinichev M, Lezmi S, Mir I, Nicoleau C, Palan S, Perier C, Raban E, Zhang S, Dong M, Stenmark P, Krupp J. Elliott M, et al. Among authors: lezmi s. Sci Adv. 2019 Jan 16;5(1):eaau7196. doi: 10.1126/sciadv.aau7196. eCollection 2019 Jan. Sci Adv. 2019. PMID: 30746458 Free PMC article.
Recombinant botulinum neurotoxin serotype A1 in vivo characterization.
Périer C, Martin V, Cornet S, Favre-Guilmard C, Rocher MN, Bindler J, Wagner S, Andriambeloson E, Rudkin B, Marty R, Vignaud A, Beard M, Lezmi S, Kalinichev M. Périer C, et al. Among authors: lezmi s. Pharmacol Res Perspect. 2021 Oct;9(5):e00857. doi: 10.1002/prp2.857. Pharmacol Res Perspect. 2021. PMID: 34632725 Free PMC article.
The Expanding Therapeutic Utility of Botulinum Neurotoxins.
Fonfria E, Maignel J, Lezmi S, Martin V, Splevins A, Shubber S, Kalinichev M, Foster K, Picaut P, Krupp J. Fonfria E, et al. Among authors: lezmi s. Toxins (Basel). 2018 May 18;10(5):208. doi: 10.3390/toxins10050208. Toxins (Basel). 2018. PMID: 29783676 Free PMC article. Review.
Comparison of the Anti-Tumour Activity of the Somatostatin Receptor (SST) Antagonist [177Lu]Lu-Satoreotide Tetraxetan and the Agonist [177Lu]Lu-DOTA-TATE in Mice Bearing AR42J SST2-Positive Tumours.
Plas P, Limana L, Carré D, Thiongane A, Raguin O, Mansi R, Meyer-Losic F, Lezmi S. Plas P, et al. Among authors: lezmi s. Pharmaceuticals (Basel). 2022 Aug 30;15(9):1085. doi: 10.3390/ph15091085. Pharmaceuticals (Basel). 2022. PMID: 36145306 Free PMC article.
55 results